Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Bachem Holding AG announced today that its Annual General Meeting 2023 has approved all proposals of the Board of Directors.
Released By Bachem
April 28, 2023
• All proposals of the Board of Directors approved. • Dividend of CHF 0.75 per share. Bachem Holding AG (“Bachem”, SIX: BANB) announced today that its Annual General Meeting 2023 has approved all proposals of the Board of Directors. The event was held with physical presence of the shareholders for the first time since 2019. A total of 84.22 % of the 74‘981‘645 eligible shares were present. The Annual General Meeting approved a dividend of CHF 0.75 per share. The dividend will be paid on April 25, 2023. The last trading day entitling to receive the dividend is April 20, 2023. As of April 21, 2023, the shares will be traded ex-dividend. Both the Chairman and the other members of the Board of Directors were re-elected for a further year. The existing members of the Compensation Committee were also re-elected for a further year. The shareholders approved the annual report, the financial statements of Bachem Holding AG, the consolidated financial statements for the business year 2022, as well as the appropriation of retained earnings and reserves from capital contributions and the total amount of the annual compensation paid to the Board of Directors and to the Corporate Executive Committee. MAZARS SA, Zurich was appointed by the Annual General Meeting as auditor of Bachem Holding AG for the business year 2023. The Annual General Meeting also approved the proposal of the Board of Directors to amend the Articles of Association. A detailed list of all resolutions is available here.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !